The Journal of dermatologyHumansAntineoplastic Combined Chemotherapy ProtocolsColitisDisease ProgressionFatal Outcome
Three Cases of Advanced Melanoma With Severe irAE Colitis With Rapid Tumor Progression Following Infliximab Administration.
Emi Yamazaki, Taku Fujimura, Yumi Kambayashi, Manami Takahashi-Watanabe, Kenta Oka, Erika Tamabuchi, Yusuke Muto, Akira Hashimoto, Yoshihide Asano
Published: 202610.1111/1346-8138.70039
Abstract
Immune checkpoint inhibitors (ICIs) have improved melanoma outcomes but can cause severe immune-related colitis. Infliximab is often used for steroid-refractory cases, yet its effect on tumor control remains uncertain. We describe three advanced mela…
Preview only. Read the full abstract at the source